Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2012.0150
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Mary Ann Liebert Inc